Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    MiPT molecular structure

    MiPT Stats & Data

    N-methyl-n-isopropyltryptamine
    NPS DataHub
    MW216.33
    FormulaC14H20N2
    CAS96096-52-5
    IUPACN-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
    SMILESCC(C)N(C)CCc1cnc2ccccc12
    InChIKeyKTQJVAJLJZIKKD-UHFFFAOYSA-N
    Tryptamines
    Chemical Class Substituted tryptamine
    Psychoactive Class Psychedelic

    Toxicity

    PsychonautWiki

    The toxicity and long-term health effects of recreational MiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because MiPT is a research chemical with very little history of human usage. Anecdotal evidence from those who have tried MiPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption. It is strongly recommended that one use harm reduction practices when using this drug.

    Effect Profile

    Curated + 15 Reports
    Psychedelic 6.1

    Strong visuals with mild auditory effects and body load, low headspace

    Visual Intensity×3
    103.8
    Headspace Depth×3
    35.4
    Auditory Effects×1
    4
    Body Load / Somatic Effects×1
    43.1
    Catalog BlueLight

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Insufflated
    0-1 minutes
    3.0-5.0 hours
    1.0-6.0 hours
    Oral
    30-45 minutes
    2.0-5.0 hours
    1.0-6.0 hours
    Smoked
    0-1 minutes
    2.0-3.0 hours
    1.0-6.0 hours

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Cross-Tolerances

    LSD
    Psilocybin
    Psilocin
    Mescaline
    DMT
    5-MeO-DMT
    2C-B
    2C-E

    Experience Report Analysis

    Erowid BlueLight
    14 Reports
    7 Single-substance
    1998–2021 Date Range
    7 With Age Data
    9 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 14 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 11 of 14
    • Female 1 of 14
    • Not Specified 2 of 14

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid + Bluelight

    Effects aggregated from 15 experience reports (7 single-substance Erowid + 8 Bluelight)

    15 Reports
    56 Effects Detected
    40 Positive
    8 Adverse
    8 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 7 single-substance Erowid and 8 analyzed Bluelight reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 40

    Contentment 6 of 8 75%
    Music Enhancement 10 of 15 89%
    Body High 5 of 8 81%
    Introspection 8 of 15 77%
    Emotional Openness 4 of 8 80%
    Focus Enhancement 4 of 8 72%
    Visual Distortions 7 of 15 72%
    Visual Trails 3 of 8 73%
    Analysis Enhancement 3 of 8 78%
    Brightness Enhancement 3 of 8 78%
    Euphoria 5 of 15 82%
    Empathy 5 of 15 80%
    Color Enhancement 4 of 15 80%
    Stimulation 4 of 15 80%
    Tingling 2 of 8 75%
    Closed-Eye Visuals 2 of 8 80%
    Peripheral Imagery 2 of 8 75%
    Visual Sharpening 2 of 8 75%
    Awe 2 of 8 75%
    Appetite Increase 2 of 8 72%

    Adverse Effects 8

    Anxiety 5 of 7 70%
    Nausea 2 of 8 78%
    Vomiting 1 of 8 70%
    Body Load 1 of 8 85%
    Tension 1 of 8 75%
    Tremor 1 of 8 75%
    Dizziness 1 of 8 65%
    Headache 1 of 8 70%
    Show 8 neutral or unclassified mentions
    Sedation 4 of 8
    Auditory Effects 3 of 7
    Pupil Dilation 2 of 8
    Heaviness 1 of 8
    Fractal Imagery 1 of 8
    Depersonalization 1 of 8
    Metallic Taste 1 of 8
    Insomnia 1 of 8

    Also reported in combinations. In the 7 MiPT reports where another drug was taken too, 0 mention hospital, emergency services or an overdose, 0 a seizure and 1 psychosis (too few reports for percentages). In the 7 single-substance reports: 1, 0 and 0. These are not in the figures above: they cannot be put down to MiPT alone, and a mention is not always something that happened to the writer.

    Real-World Dose Distribution

    Erowid

    From 12 of 18 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=12)

    Median: 24.5mg 25th: 20.0mg 75th: 42.5mg 90th: 63.5mg

    Common Combinations

    Most co-occurring substances, as a share of all 14 reports filed under MiPT

    Too few reports for bars: these combinations come from 14 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • THC 6 of 14

    Form / Preparation

    Most common forms and preparations, as a share of the 10 reports that give one

    Too few reports for bars: these forms come from 10 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 5 of 10
    • Capsule 4 of 10

    Redose Patterns

    Redosing behavior across 10 reports

    3 of 10 Redosed
    1.4 Avg Doses
    4m Median Interval

    Too few reports for a chart: redosing is known from 10 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Single dose 7 of 10
    • Redosed 3 of 10
    ← Back to MiPT